Patients and Surfaces: Integrated Clinical–Environmental Surveillance of MDR Gram-Negative Bacteria in Critical-Care Units (Karachi, 2024–2025)
Open Access
- 4 December 2025
- journal article
- research article
- Published by MDPI AG in Microorganisms
- Vol. 13 (12) , 2762
Abstract
Carbapenem-resistant Gram-negative (CR-GN) pathogens pose a critical threat to patient outcomes in high-dependency and intensive care environments. This study aimed to delineate species prevalence, antimicrobial resistance phenotypes, carbapenemase genotypes, and clinical–environmental transmission dynamics across critical-care units. Cross-sectional surveillance was conducted in six ICUs and HDUs of a tertiary-care hospital in Karachi, Pakistan. We identified predominant species, quantified resistance patterns, and detected carbapenemase genes using PCR, exclusively on meropenem-resistant isolates. Network analysis highlighted high-centrality contamination hubs across ICUs and HDUs. Acinetobacter baumannii (36.7%) and Klebsiella pneumoniae (33.9%) were predominant, with 58% originating from environmental reservoirs. Meropenem non-susceptibility was 55% (60/109), and colistin non-susceptibility was 68.6% (35/51), based on standardized CLSI testing. ICU isolates exhibited significantly higher meropenem resistance than HDU isolates. Among carbapenem-resistant isolates, blaOXA-48-like (52.8%) and blaNDM (25%) were most prevalent. Network topology revealed ICU1 and HDU2 as high-centrality transmission nodes. These findings highlight pervasive environmental colonization and heightened antimicrobial pressure in ICUs, necessitating reinforced decontamination protocols, antimicrobial stewardship, and continuous molecular surveillance. This study provides the first integrated clinical–environmental surveillance of MDR Gram-negative bacteria in Pakistan, revealing that over half of isolates originated from surfaces and that network-based mapping can pinpoint contamination hubs driving hospital transmission.Keywords
Funding Information
- Dow University of Health Sciences, Vice Chancellor’s Seed Fund Initiative (DUHS/VC/2023/11-04/18)
This publication has 46 references indexed in Scilit:
- Understanding the landscape of carbapenemase-producing organisms (CPOs), and spotlighting opportunities for control in EnglandInfection Prevention in Practice, 2025
- Infection prevention and control measures for multidrug-resistant organisms: a systematic review and network meta-analysisInfection, 2025
- Prevalence of carbapenem-resistant Enterobacterales (CRE) in Saudi Arabia: A systematic review and meta-analysisSaudi Pharmaceutical Journal, 2024
- Prediction of multidrug-resistant bacteria (MDR) hospital-acquired infection (HAI) and colonisation: A systematic reviewInfection, Disease & Health, 2024
- A systematic review and meta-analysis of carbapenem resistance and its possible treatment options with focus on clinical Enterobacteriaceae: Thirty years of development in PakistanHeliyon, 2024
- Response to antimicrobial resistance in South-East Asia RegionThe Lancet Regional Health - Southeast Asia, 2023
- Sulbactam‐durlobactam: A novel β‐lactam‐β‐lactamase inhibitor combination targeting carbapenem‐resistant Acinetobacter baumannii infectionsPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2023
- Mechanistic Basis of OXA-48-like β-Lactamases’ Hydrolysis of CarbapenemsACS Infectious Diseases, 2021
- Multiplex PCR for detection of acquired carbapenemase genesDiagnostic Microbiology and Infectious Disease, 2011
- Frequent Multidrug-ResistantAcinetobacter baumanniiContamination of Gloves, Gowns, and Hands of Healthcare WorkersInfection Control & Hospital Epidemiology, 2010